Načítá se...
Overcoming Resistance to the THZ Series of Covalent Transcriptional CDK Inhibitors
Irreversible inhibition of transcriptional cyclin-dependent kinases (CDKs) provides a therapeutic strategy for cancers that rely on aberrant transcription; however, lack of understanding of resistance mechanisms to these agents will likely impede their clinical evolution. Here, we demonstrate upregu...
Uloženo v:
| Vydáno v: | Cell Chem Biol |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6389506/ https://ncbi.nlm.nih.gov/pubmed/29276047 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.chembiol.2017.11.007 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|